HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia
Kiave-Yune HoWangYin, Céline Loinard, Wineke Bakker, Coralie L. Guérin, José Vilar, Clément d’Audigier, Laëtitia Mauge, Patrick Bruneval, Joseph Emmerich, Bernard Lévy, Jacques Pouysségur, David M. Smadja, Jean‐Sébastien Silvestre (2013). HIF-Prolyl Hydroxylase 2 Inhibition Enhances the Efficiency of Mesenchymal Stem Cell-Based Therapies for the Treatment of Critical Limb Ischemia. , 32(1), DOI: https://doi.org/10.1002/stem.1540.
